No Detail Found!

A meta-analysis for the efficacy and safety of direct oral anticoagulants versus vitamin k antagonists for left ventricular thrombus

Author(s)
Gian Chand National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Abdul Hameed National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Rukhsar Bibi National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Iram Jehan Balouch National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Ijaz Ul Haq National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Muhammad Tahseen Raza National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Ahmed Raheem Aga Khan University Hospital,Karachi,Pakistan
Abstract
Objectives: The objective of this updated meta-analysis is to consolidate high-quality peerreviewed clinical evidence, including trials and observational studies, to evaluate the efficacy and safety of “direct oral anticoagulants (DOACs)” versus “vitamin K antagonists (VKAs)” for treating “left ventricular thrombus (LVT)”. Methodology: We included studies of either "observational" or "experimental" in nature reported original data for the head-to-head comparison of "DOACs" and "VKAs" for the treatment of LVT. The efficacy-related outcome of interest was "thrombus resolution" and safety-related outcomes of interest were; "mortality", "major bleeding", and "stroke". The “risk ratios (RRs)” for each outcome variable were calculated using the “Mantel -Haenszel method”. Results: The analysis included 19 studies comprised of 3,027 patients diagnosed with LVT. Among them, 881 received DOAC treatment, while 2,146 were treated with VKAs. DOACs showed comparable rates of LVT resolution (RR: 1.00 [0.93 - 1.08]), lower mortality incidence (RR: 0.65 [0.51 - 0.84]), similar stroke incidence (RR: 0.83 [0.61 - 1.14]), and similar major bleeding incidence (RR: 0.71 [0.50 - 1.00]) compared to VKAs. Conclusion: The meta-analysis indicates that DOACs are as effective as VKAs for treating LVT, showing comparable thrombus resolution rates, lower all -cause mortality, similar stroke risks, and clinically relevant bleeding across studies. However, these conclusions are limited by the lack of evidence from large-scale randomized studies and high-quality real-life clinical data.
Publication Details
Page(s) 211-218
Published Journal: Pakistan Heart Journal, Volume: 56, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Safety, Meta-analysis, efficacy, Left ventricular thrombus, direct oral anticoagulants, vitamin K antagonists
0

Citations

0

Downloads

46

Views